intercostal space, bilateral crackles and wheeze, R. infraaxillary breath sounds diminished, L. infraclavicular bronchial breathing. CVS: normal heart sounds, no murmur. Pancreatic lipase, hypertonic saline, calories, protein, MCT oil, chest physiotherapy. He was given blood transfusion for anemia on Dec 09. Respiratory rate remained >50/minute, chest findings persisted, oxygen requirement persisted. On day 5, he developed increasing respiratory distress and pedal edema (but no hepatomegaly or raised JVP). On day 7, he had altered sensorium, E2M4V3, low K+, low blood sugar, worsening respiratory distress intermittent positive pressure respiratory (IPPR). Multiple episodes of desaturation and bradycardia (lack of IPPR), worsening shock, dopamine at 10 to 15µg/kg/, in cardiorespiratory arrest, declared dead on Dec 08, 2016. where 10-year-old child with cough, rapid breathing with regular exacerbation, and failure to thrive, both weight and height less than 3SD,clubbing and increased AP diameter. During admission, blood gas analysis showed hypochloremic alkalosis, imaging studies revealed bronchiectasis and sputum grew Pseudomonas. Clinically, it can be nothing other than CF. These children are known to have exacerbation and high predilection for colonization Aspergillus in this phase. Aspergillus sensitization is prevalent up to 40%; ABPA is there in 18% of children, matching with closest data from the All India Institute of Medical Sciences. Total IgE elevated as well as Aspergillus fumigatus-specific IgE elevated, there was no going away from ABPA. Ultimately what took away the child was pneumonia with any organism, most likely tuberculosis.
Date Hb (g/dL) TLC (/mm3) DLC (P/L/M/E)

Platelets (/mm3) MCV (fL) MCH (pg) MCHC (g/dL) RDW (%) ESR (mm)
Treating unit SR: I'm the senior resident who was managing the case when the child was in ward. Child presented with characteristic chronic lung disease, our possibilities was CF with ABPA. Apart from the diagnostic algorithm which was shown in the presentation, facilities for mutation and sweat chloride were not available. Characteristic clinical features can be supported with blood gas analysis and stool for fat globules in resource-limited setting, and any of the two abnormalities, if present, the case can be labeled as suspected CF and management can be started in form of enzyme replacement therapy and soluble vitamin supplements. In view of rapid downhill course in this case, we suspected Aspergillus infection. A total of 11 to 15% of CF are associated with Aspergillus, out of them 30% are invasive aspergillosis, which can lead to rapid downhill course as is expected in this case.
Prof S Varma: There does not seem to be difference of opinion so far. Any other comments? Dr Vivek (Nephrology): You have mentioned that probably next most common cause is idiopathic bronchiectasis. What is the usual age of presentation of these? If they present in early childhood, how can we clinically differentiate these from CF? Is there any urine analysis report?
Dr Pankaj Vaidhya (Pediatrics): A total of 30% of CF patients can have liver involvement in the form of biliary cirrhosis and venous congestion. Our case had hypoalbuminemia, although clinically only 3 to 4% have liver manifestations; we are expecting changes in liver.
Prof S Varma: It seems that there is no urine analysis report.
Resident (Pediatrics): Can it just be aspergillussensitive asthma? Is there any role of exhaled nitric oxide measurement in differentiating these two conditions? Dr Meenu Singh: Although clinically classically fitting into CF, ways to approach these patients are different.
When these patients with bronchiectasis come to us, if there is bronchiectasis or features of airway obstruction, then we think more in terms of CF. ABPA is something that can occur in asthma; if they have uncontrolled asthma which can be colonized with Aspergillus, they can develop ABPA, leading to bronchiectasis and all the classical features, which can mimic CF. Only odd point is clubbing and growth retardation, which point toward lung suppuration. Sputum has grown Pseudomonas that also favors CF than ABPA with asthma and Aspergillussensitized asthma. Non-CF organisms like TB are unlikely. Aspergillus presents as colonization here, rather than hypersensitive response. In patients treated with steroids for a long time, this fungus tends to be invasive and one may get invasive aspergillosis.
Resident (Pediatrics): Exhaled nitric oxide has certain distinguishing value; it is not elevated in CF bronchiectasis.
Prof S Varma: Any new questions? Dr Vignesh (Pediatrics): Although clinical manifestation fit into CF, lab findings do not fit into CF. Apart from CF, can we think of hyper IgE syndrome as we have increased IgE and can we go for STATA3 mutation?
Prof S Varma: I think we have discussed about this. That needs to be talked about later.
Resident (Pediatrics): My comment is about ultimate deterioration on day 5. The child was transfused on day 5; I do not know what was the chronology of deterioration and transfusion, I would like to keep a possibility of TRALI.
Dr Vignesh (Pediatrics): I would like to differ from basic diagnosis. I would like to keep primary immunodeficiency (PID) and workup needs to be performed. IgM is not normal in this patient, it was on lower side, i.e., at −2SD. IgG is very high. It might be one of the subclasses of PID. If one of these deficiencies is there, in lymph node biopsy we can see B-cell depletion.
Dr Mathew: Though one-third of patients can have liver disease, in this case, it does not suggest liver disease, because coagulation profile and enzyme levels are normal. Hypoalbuminemia can be explained by chronic malnutrition.
Prof S Varma: In the absence of urine examination, we cannot exclude amyloid in this child with recurrent infection for a long period of time.
Dr Joseph: I was also carried away with the IgE but hyper IgE syndrome includes not just bronchiectasis but also staphylococcal boils or pustule and that was not there in this particular child. IgG2 and IgG4 subclass deficiency cannot be ruled out till we have those values. Asthma starting as the primary diagnosis and in exclusion CF is unlikely for the reasons we have already mentioned. Transfusion started on day 5 and deterioration started on day 7. So there was a 36 to 48 hours gap between the two events. There was an alteration in sensorium associated with hypoglycemia and hypokalemia, so either there is some metabolic cause for the initial deterioration or there is something in CNS which has not manifested clinically. I think despite the discussion, CF with this kind of presentation remains the first possibility in this child.
Prof (Fig. 5) .
Gall Bladder: Normal. Spleen: Weighs 90 gm. Grossly and microscopically they are within normal limits.
Heart: Weighs 110 gm. All valves and chambers are within normal limits. Except for mild RVH (0.6cm). Microscopically they are within normal limits.
Thymus: Normal for age. Mediastinal lymph nodes: Enlarged (3-4 cm).Microscopically, focal necrotizing lymphadenitis with wellpreserved T-and B-cell zones are noted.
Kidneys: Weigh 170 gm. Grossly, capsular surface shows mild hemorrhagic discoloration, along convex border. Cut surface shows medullary congestion. Microscopically, sclerosed glomeruli (more than expected for age) with immature glomeruli, features of acute pyelonephritis and ATN with granular casts are seen (Fig. 6) .
Adrenals: Weigh 8 gm. Gross and microscopically are within normal limits. Prof Sanjay Jain: I was listening to this debate between CF and ABPA. Let me tell you very frankly, clinicians have advantage of looking at the clinical parameter; there is no other situation if somebody has got B/L bronchiectasis and Pseudo-Bartter Syndrome. It has to be CF. How can you expect CO 2 to be 90% to be in a patient of asthma? This is a classic patient of bronchiectasis, there is no h/o wheeze. Asthma classically has cough, dyspnea, and wheeze. This patient had respiratory tract infection. ABPA sets in a setting of asthma. Where is the asthma? Component of bronchospasm and CO 2 retention does not occur. This is a classical Pseudo-Bartter Syndrome. How do you explain metabolic alkalosis? With due respect to microbiologists, this is not ABPA. This is CF whether or not you have genetic analysis. When there is diarrhea and metabolic alkalosis in a child, CF would be the diagnosis. Otherwise in a developing world, where the genetic analysis is not available, how would you diagnose CF without missing out?
Dr Ashish: Nice demonstration of pathology. Not finding any organism in lung is odd, when you have significant amount of neutrophilic exudates and all the respiratory bronchioles are clogged. I look at it in two ways. On culture, on day 8 we grew Pseudomonas which is sensitive. Either we were doing it too well clinically in eradicating Pseudomonas or there is something wrong, otherwise Pseudomonas in CF is difficult to eradicate. Why are there giant cells? Prof S Varma: Histology is a poor indicator of bacteria and this might be the reason.
Dr Meenu: This is in response to Dr Jain's comment. There is no doubt about CF. The doubt is whether there is ABPA. We still can not rule out. In fact it is, as Dr Chakrabarti mentioned. Hyperattenuated mucus is seen in ABPA as a secondary thing to asthma. In CF, mucus is very rich in DNA, as there are many neutrophils. Another thing is hyperattenuated mucus which is detected radiologically. I'm still doubtful, whether CF produces hyperattenuating mucus. So, ABPA is there, since the criteria are fulfilled. There are about 2,000 mutations; this patient might carry any of these. We are really impressed by pancreatic, testicular, and vas deferens changes, which is never seen clinically. How to detect it in ultrasound is always a problem.
Prof S Varma: When you are having hypersensitivity, it does not tell you where the organism is present. Aspergillus
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in sinus could give rise to this picture. I mean to say that ABPA could not be ruled in or ruled out. We are at this moment dealing with pathology, i.e., definitely CF, we have test abnormalities that we need to explain. For that we do not have adequate explanation in lung as of now. We have not looked at the sinuses of this child. So, we can not say anything. Dr Pankaj Vaidhya: This is regarding risk factor for progression of disease in children with CF and ABPA; as they grow older, they colonize Pseudomonas and along with poor nutrition status, the prognosis worsens.
Dr Kirti Gupta: Pathology also questions the existence of ABPA in this patient. Because bronchiocentric granuloma, allergic mucin, eosinophilic pneumonia were absent. Allergic mucin, charcot-Leyden crystals are not seen. Mucin was rich predominantly in neutrophils, not eosinophils. Regarding giant cells, they are predominantly foreign body type, produced in response to the destruction of elastic tissue of vessel wall and they are centered on bronchioles.
Dr Joseph: On the one hand, I'm pleased because the final diagnosis is similar to the initial diagnosis at the emergency. Two days later pulmonology unit also worked up on the same line. My own findings are not different from autopsy findings including pulmonary hypertension and wolffian duct abnormality. Mutation sometimes correlates with clinical phenotype; if it is very severe like if I have a homologous Delta508 deletion then the clinical picture pretty much looks like this. But the lung pathology and the changes need not correlate with the mutation, unless severe mutations are there. The fact that mutation study is not available did not take away from CF. Regarding ABPA, we should remember, the child has been treated with steroids and antifungals for the past 2 months, which might have changed the picture. Important thing is, adding ABPA in the diagnosis is that there is treatment for it. If it is there, we will add antifungals and steroids. The last comment is of course that, children with CF might have asthma-like symptoms (wheeze). Outside this institute, these cases are treated with bronchodilators and nebulizers, sometimes mislabeled as asthma. It is possible that fungal infection might have come from those nebulizers which were never cleaned.
Prof S Varma: We had excellent demonstration of CF. I'm not sure whether now ABPA is there despite treatment. I must complement the JR pediatrics for the enthusiastic participation in the discussion.
DISCUSSION
Cystic fibrosis is a genetic disorder driven by cystic fibrosis transmembrane conductance regulator (CFTR) mutations that affect the exocrine glands. It is an autosomal recessive mode of inheritance. Twenty-five years ago, a variant (p.Phe508del; also known as F508del) in the CFTR gene was found to be the most common cause of cystic fibrosis. Historically, CFTR variants have been grouped into five (and sometimes six) functional classes. The class system provides a useful framework for understanding the primary defect at the cellular level.
A diagnosis of cystic fibrosis is based on the presence of clinical findings, along with an elevated sweat chloride concentration (>60 mM). The degree of organ system dysfunction varies considerably among affected individuals. Genetic modifiers and nongenetic factors both contribute to airway obstruction and infection with Pseudomonas aeruginosa -two traits that define lung disease in cystic fibrosis. The CFTR genotype is the primary determinant of the degree of pancreatic exocrine dysfunction. The presence of CFTR variants associated with severe pancreatic exocrine dysfunction is essentially a prerequisite for the development of diabetes and intestinal obstruction. In the setting of severe endocrine dysfunction, genetic modifiers determine when, and if, diabetes occurs and whether neonatal intestinal obstruction occurs.
The key histological features of ABPA include bronchocentric granulomas, eosinophilic pneumonia, and allergic mucin, which were classically missing in this case.
Absence of vas deferens is another feature often encountered and cause of male infertility.
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